Ken Fisher Abb Vie Inc. Transaction History

Fisher Asset Management, LLC

$213 Billion
Q1 2024

A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Abb Vie Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 33,923 shares of ABBV stock, worth $5.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,923

Previous 33,909 0.04%

Holding current value

$5.47 Million

Previous $5.25 Million 17.57%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $2,237 - $2,549	14 Added 0.04%	33,923 $6.18 Million
Q4 2023 Mar 05, 2024	SELL	$137.6 - $154.97 $170,211 - $191,697	-1,237 Reduced 3.52%	33,909 $5.25 Million
Q4 2023 Feb 06, 2024	SELL	$137.6 - $154.97 $251,532 - $283,285	-1,828 Reduced 4.94%	35,146 $5.45 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $876,617 - $1.01 Million	6,562 Added 21.58%	36,974 $5.51 Million
Q2 2023 Dec 12, 2023	SELL	$132.51 - $164.9 $869,530 - $1.08 Million	-6,562 Reduced 17.75%	30,412 $4.1 Million

Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $352,079 - $438,139	2,657 Added 9.57%	30,412 $4.1 Million
Q1 2023 Dec 12, 2023	SELL	$144.61 - $166.54 $1.37 Million - $1.58 Million	-9,482 Reduced 25.65%	27,492 $4.38 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $354,439 - $408,189	-2,451 Reduced 8.11%	27,755 $4.42 Million
Q4 2022 Feb 03, 2023	SELL	$138.31 - $165.87 $871,767 - $1.05 Million	-6,303 Reduced 17.26%	30,206 $4.88 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $100,791 - $115,601	751 Added 2.1%	36,509 $4.9 Million
Q2 2022 Aug 09, 2022	BUY	$137.62 - $174.96 $290,102 - $368,815	2,108 Added 6.26%	35,758 $5.48 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $462,985 - $574,435	-3,508 Reduced 9.44%	33,650 $5.46 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $202,398 - $256,092	1,884 Added 5.34%	37,158 $5.03 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $368,144 - $417,898	3,460 Added 10.88%	35,274 $3.81 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $37,033 - $41,257	352 Added 1.12%	31,814 $3.58 Million
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $163,475 - $179,966	-1,598 Reduced 4.83%	31,462 $3.41 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $272,056 - $367,304	3,380 Added 11.39%	33,060 $3.54 Million
Q3 2020 Nov 10, 2020	SELL	$85.91 - $100.83 $149,569 - $175,545	-1,741 Reduced 5.54%	29,680 $2.6 Million
Q2 2020 Aug 07, 2020	BUY	$73.37 - $98.18 $215,487 - $288,354	2,937 Added 10.31%	31,421 $3.09 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $17.5 Million - $26.5 Million	-271,252 Reduced 90.5%	28,484 $2.17 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $8.68 Million - $10.9 Million	-120,362 Reduced 28.65%	299,736 $26.5 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $237,938 - $286,070	-3,778 Reduced 0.89%	420,098 $31.8 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $17.6 Million - $22.6 Million	-268,584 Reduced 38.79%	423,876 $30.8 Million
Q1 2019 Apr 22, 2019	SELL	$77.14 - $90.79 $9.3 Million - $11 Million	-120,616 Reduced 14.83%	692,460 $55.8 Million
Q4 2018 Jan 25, 2019	SELL	$77.85 - $96.01 $254,880 - $314,336	-3,274 Reduced 0.4%	813,076 $75 Million
Q3 2018 Oct 24, 2018	BUY	$88.91 - $98.84 $1.38 Million - $1.54 Million	15,559 Added 1.94%	816,350 $77.2 Million
Q2 2018 Jul 09, 2018	BUY	$89.78 - $106.23 $2.24 Million - $2.66 Million	24,999 Added 3.22%	800,791 $74.2 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $12.2 Million - $16.4 Million	-132,757 Reduced 14.61%	775,792 $73.4 Million
Q1 2018 Apr 19, 2018	BUY	$92.01 - $123.21 $27.2 Million - $36.5 Million	295,899 Added 48.3%	908,549 $86 Million
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $6.33 Million - $6.94 Million	-70,624 Reduced 10.34%	612,650 $59.2 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $47.7 Million - $61 Million	683,274	683,274 $60.7 Million

Others Institutions Holding ABBV

# of Institutions

3,643

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $285B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track Ken Fisher's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Account